Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk

April 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …
Feature
abbvie_0

AbbVie’s Skyrizi snatches up FDA approval in moderate to severe plaque psoriasis

April 24, 2019 Research and Development, Sales and Marketing AbbVie, FDA, Skyrizi, US, pharma, psoriasis

AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the FDA …
News

Eli Lilly sell Chinese rights to two antibiotics in deal worth $375 million

April 24, 2019 Research and Development

US firm Eli Lilly has agreed to sell the Chinese rights to two of its antibiotics, Ceclor (cefaclor) and Vancocin …
News
636674328233382711-sd-071718-opioids-b-metro

Former pharma wholesaler execs face criminal charges over opioid crisis

April 24, 2019 Research and Development Litigation, RDC, Rochester Drug Cooperative, opioid crisis, opioids

Laurence Doud III, the former CEO of New York-based Rochester Drug Co-operative (RDC) – one of the largest drug distributors …
News
teva_copy

Teva terminates Ajovy at Phase 3 in episodic cluster headache

April 24, 2019 Research and Development Teva, ajovy, headache, pharma

Israeli pharmaceutical firm Teva has announced its intention to terminate further development of its calcitonin gene-related peptide (CGRP) inhibitor Ajovy …
News

Novartis reveals promising interim Phase 3 data for gene therapy Zolgensma in spinal muscular atrophy

April 18, 2019 Research and Development Novartis, Zolgensma, pharma

Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma (onasemnogene …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
News

CBD could be used to deliver drugs into the brain, research shows

April 18, 2019 Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience

Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …
News

Doctors cure ‘bubble boy syndrome’ using modified version of HIV

April 18, 2019 Research and Development HIV, SCID-X1, gene therapy, immunodeficiency, immunology

Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1) – …
News
andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Appointment
icl

Imperial College London researchers developing tech to monitor dementia patients at home

April 17, 2019 Research and Development dementia, imperial college london, pharma

Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …
News
ms_pharma

MS Pharma ink deal for acquisition of Genepharm

April 17, 2019 Research and Development

Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. …
News

NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease

April 17, 2019 Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK

Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …
News
chinese_flag_beijing_-_img_1104

China introduces new laws to ensure steady supply of drugs

April 17, 2019 Research and Development China, National Health Commission, laws, markets, pharma, regulation

China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …
News
gsk_ulverston_plant_impression

GSK to make redundancies at plant in Stevenage

April 17, 2019 Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026